Brevan Howard Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-131,987
| Closed | -$1.05M | – | 1899 |
|
|
2025
Q1 | $1.05M | Buy |
+131,987
| New | +$1.05M | 0.01% | 440 |
|
|
2024
Q4 | – | Sell |
-16,847
| Closed | -$122K | – | 1342 |
|
|
2024
Q3 | $122K | Sell |
16,847
-26,569
| -61% | -$192K | ﹤0.01% | 1002 |
|
|
2024
Q2 | $471K | Buy |
43,416
+23,515
| +118% | +$255K | ﹤0.01% | 580 |
|
|
2024
Q1 | $373K | Sell |
19,901
-1,366
| -6% | -$25.6K | ﹤0.01% | 521 |
|
|
2023
Q4 | $461K | Buy |
+21,267
| New | +$461K | 0.01% | 473 |
|